Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Translational approaches using metastasis suppressor genes.

Diane Palmieri1, Christine E Horak, Jong-Heun Lee

  • 1Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Building 37, Room 1122, NIH, Bethesda, MD 20892, USA.

Journal of Bioenergetics and Biomembranes
|September 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+ brain metastasis model systems.

Neuro-oncology·2026
Same author

Proteogenomic characterization of invasive breast tumors in young women.

NPJ breast cancer·2025
Same author

Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health.

The Lancet. Oncology·2024
Same author

Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+ brain metastases of breast cancer.

Neuro-oncology·2024
Same author

The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study.

Clinical & experimental metastasis·2023
Same author

A perspective on the metastasis suppressor field.

Cancer metastasis reviews·2023

Understanding metastasis suppressor genes like nm23 (NDP kinase) is crucial for developing new anti-metastatic therapies. Research explores nm23

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer metastasis significantly increases patient mortality.
  • Metastasis suppressor genes inhibit metastasis without impacting primary tumor growth.
  • Nm23 (NDP kinase) is the first and most validated metastasis suppressor gene.

Purpose of the Study:

  • To elucidate the biological and biochemical mechanisms of Nm23-mediated metastasis suppression.
  • To explore potential therapeutic strategies targeting metastasis.

Main Methods:

  • Utilized transfection and knock-out mouse models to study nm23 function.
  • Investigated potential biochemical mechanisms including protein binding and histidine kinase activity.

Main Results:

Related Experiment Videos

  • Nm23 is a validated suppressor of cancer metastasis.
  • The precise biochemical mechanism of Nm23 remains under investigation.
  • Potential mechanisms involve protein interactions and enzymatic activity.

Conclusions:

  • Understanding Nm23 is key to developing anti-metastatic therapies.
  • Elevating Nm23 expression may limit metastatic colonization in high-risk patients.
  • Medroxyprogesterone acetate (MPA) is a potential therapeutic candidate.